about
Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cellsEstrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cellsTE = 32 ms vs TE = 100 ms echo-time (1)H-magnetic resonance spectroscopy in prostate cancer: Tumor metabolite depiction and absolute concentrations in tumors and adjacent tissues.Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival.Identification of FISH biomarkers to detect chromosome abnormalities associated with prostate adenocarcinoma in tumour and field effect environment.Spatially resolved optical and ultrastructural properties of colorectal and pancreatic field carcinogenesis observed by inverse spectroscopic optical coherence tomographyVariability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention.Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect.Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma.Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approachCancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcomeExpression of the stress response oncoprotein LEDGF/p75 in human cancer: a study of 21 tumor types.Development of a nuclear morphometric signature for prostate cancer risk in negative biopsies.Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencingNuclear Ep-ICD expression is a predictor of poor prognosis in "low risk" prostate adenocarcinomasNanocytological field carcinogenesis detection to mitigate overdiagnosis of prostate cancer: a proof of concept studyProstate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissueAltered PCA3 and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates: a systematic, quantitative mRNA analysis in five prostatesHigh Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting.Adaptive (TINT) Changes in the Tumor Bearing Organ Are Related to Prostate Tumor Size and Aggressiveness.Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization.Markers of field cancerization: proposed clinical applications in prostate biopsiesExtratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor GrowthHigh Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful WaitingDNA Methylation-Mediated Downregulation of DEFB1 in Prostate Cancer CellsNuclear iASPP may facilitate prostate cancer progression.Melanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44.Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis.Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer.A Phase II Randomized Trial of Lycopene-Rich Tomato Extract Among Men with High-Grade Prostatic Intraepithelial Neoplasia.Novel cancerization marker, TP53, and its role in distinguishing normal tissue adjacent to cancerous tissue from normal tissue adjacent to benign tissueEpigenetic influences in the aetiology of cancers arising from breast and prostate: a hypothesised transgenerational evolution in chromatin accessibilityHarnessing novel modalities: field carcinogenesis detection for personalizing prostate cancer management2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in benign prostate and subsequent risk for prostate cancerMethylation of the RARB gene increases prostate cancer risk in black AmericansAssociation and regulation of protein factors of field effect in prostate tissues.Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer.Aberrant chimeric RNA GOLM1-MAK10 encoding a secreted fusion protein as a molecular signature for human esophageal squamous cell carcinoma.Biomarkers for prostate cancer: present challenges and future opportunities.
P2860
Q24619475-993DC77B-0C7A-438C-B83E-24E96F3B28F0Q30426649-8E2F628D-6FA2-48B0-A814-2AA89EB2E9D6Q30986225-E01B1569-4576-452F-844A-1B7D17EA74A2Q33588577-37932751-2B00-4CAC-8681-0C0552FE7582Q33592442-4B256F73-5C2B-4FA9-B0A8-271226A8AA49Q33604116-327279D8-56FB-4F90-8F96-3822B9D8A314Q33658285-267DE67B-DC60-48FA-9D6C-2D61D86CBDE9Q33714055-BF6834A9-38E6-469F-8221-C1B7972DADECQ33753890-9FB8A6F3-9F1D-4BAF-8AFB-5514347B2FF5Q33770342-B82BF889-AA07-4DC0-9748-E65D46E73FAAQ33920767-F42DF119-11F2-4B91-BC14-DE9A03910462Q34028208-5ECE810B-4EC5-47D8-A408-714E8FC6F456Q34140345-26259D76-3939-4045-969C-A21E98AC88D4Q34902668-ED09A567-3487-41BD-B2E4-0A12BD6E5B5DQ35022099-A935C914-14A9-4D2F-809E-242F4254DF40Q35103343-3AF9167D-6319-42F6-BD94-A6D3F7539E88Q35112929-070EC1D5-5B4A-4CB2-BBA1-2BF161C74F8CQ35175108-FE11A4EA-6FA3-4918-B829-82C162DA71C4Q35751842-5F568395-B094-48F6-8BDB-3A39610C3EDBQ35821224-92FF52F6-C46D-4D51-BB77-67DD7F830C33Q35832067-4C47FC88-7434-4EC4-AB2E-CEB7EDEBC579Q35923141-9FFDA59A-7A6C-45A0-9FCD-4A4A3C6A75F5Q35991148-80D6ED59-9B26-474C-A1BD-7278F0430426Q36046653-1AAC1AC7-0477-49D1-B67B-76C42D5105DEQ36168963-87717EE8-99BD-451D-98E6-4FCA19A438C4Q36190050-5E5E7464-BE25-4DE2-B091-E1BF3F38B365Q36291156-638E7FA9-81D4-4206-A527-E308B049D4D6Q36298393-D62C805A-ADA2-4309-A99F-2C34D02ABF9AQ36363019-99F1A2A9-009D-424E-B944-53701EED6530Q36447329-FE3CCF97-5A6D-4425-A0DE-DB0CDB7E1F92Q36531394-1555A976-DEF4-4C06-924F-0872B997E1B0Q36531572-0FCE0D06-BDCB-4053-91FF-486B8D70C916Q36616423-2C56C96E-3307-4D25-A935-C8C14D5FCCA0Q36904803-4D76DCD9-B129-4F7D-896E-C2982C62D0D9Q36909164-E8E9E578-042D-4FA1-AFFE-B750A20B4915Q37187963-2FFE9376-8827-4989-957B-250D7FF2AEA2Q37252687-752E54A0-70EA-4337-A37D-A426B73FF623Q37301123-7DF5B306-0865-427B-9154-CBFAD2F49A50Q37420203-558C7FC5-B308-47D3-ACF6-A62AC9DABDEBQ37474443-A9B81CBD-1FF8-4208-98C0-EC5533CCA143
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Evidence for field cancerization of the prostate.
@ast
Evidence for field cancerization of the prostate.
@en
Evidence for field cancerization of the prostate.
@nl
type
label
Evidence for field cancerization of the prostate.
@ast
Evidence for field cancerization of the prostate.
@en
Evidence for field cancerization of the prostate.
@nl
prefLabel
Evidence for field cancerization of the prostate.
@ast
Evidence for field cancerization of the prostate.
@en
Evidence for field cancerization of the prostate.
@nl
P2093
P2860
P356
P1433
P1476
Evidence for field cancerization of the prostate.
@en
P2093
Larisa Nonn
Peter H Gann
Vijayalakshmi Ananthanarayanan
P2860
P304
P356
10.1002/PROS.20983
P577
2009-09-01T00:00:00Z